APA (7th ed.) Citation

LCP, G., O, R., V, M., C, B., A, B., G, P., . . . M, D. (2026). STK17A (DRAK1) at the crossroads of apoptosis, immunity, and cancer: Emerging roles and therapeutic opportunities. Theranostics, 16(11), 5830. https://doi.org/10.7150/thno.129910

Chicago Style (17th ed.) Citation

LCP, Gonçalves, Rastoin O, Morozova V, Buzet C, Bennetot A, Pagès G, Ronco C, and Dufies M. "STK17A (DRAK1) at the Crossroads of Apoptosis, Immunity, and Cancer: Emerging Roles and Therapeutic Opportunities." Theranostics 16, no. 11 (2026): 5830. https://doi.org/10.7150/thno.129910.

MLA (9th ed.) Citation

LCP, Gonçalves, et al. "STK17A (DRAK1) at the Crossroads of Apoptosis, Immunity, and Cancer: Emerging Roles and Therapeutic Opportunities." Theranostics, vol. 16, no. 11, 2026, p. 5830, https://doi.org/10.7150/thno.129910.